Abstract
Purpose
The Hospital Anxiety and Depression Scale (HADS) is the most extensively validated scale for screening emotional distress in cancer patients. However, thresholds for clinical decision making vary widely across studies. A meta-analysis was conducted with the aim of identifying optimal, empirically derived cut-offs.
Methods
PubMed, Embase, and PsycINFO databases were searched for studies that compared the HADS total and its subscale scores against a semi-structured or structured clinical interview as a reference standard with regard to its screening efficacy for any mental disorders and depressive disorders alone. Separate pooled analyses were conducted for single or two adjacent thresholds. A total of 28 studies (inter-rater agreement, κ = 0.86) were included.
Results
The best thresholds for screening for mental disorders were 10 or 11 on the HADS total (sensitivity 0.80; specificity 0.74), 5 on the HADS depression subscale (sensitivity 0.84; specificity 0.50), and 7 or 8 on the HADS anxiety subscale (sensitivity 0.73; specificity 0.65). Respective thresholds for depression screening were 15 for the HADS total (sensitivity 0.87; specificity 0.88), 7 for the HADS depression subscale (sensitivity 0.86; specificity 0.81), and 10 or 11 for the HADS anxiety subscale (sensitivity 0.63; specificity 0.83).
Conclusions
The HADS anxiety subscale performed worse than the total and the depression subscales for both indicators. Diagnostic accuracy varied widely by threshold but was consistently superior for depression screening than for screening of any mental disorder.
Similar content being viewed by others
References
Anonymous (1999) NCCN practice guidelines for the management of psychosocial distress. Oncology (Huntington) 13:113–147
Vodermaier A, Linden W, Siu C (2009) Screening for emotional distress in cancer care. A systematic review of assessment instruments. J Natl Cancer Inst 101:1464–1488
Pirl WF, Muriel A, Hwang V, Kornblith A, Greer J, Donelan K, Greenberg DB, Temel J, Schapira L (2007) Screening for psychosocial distress: a national survey of oncologists. J Support Oncol 5(10):499–504
Mitchell AJ, Kaar S, Coggan C, Herdman J (2008) Acceptability of common screening methods used to detect distress and related mood disorders—preferences of cancer specialists and non-specialists. Psychooncology 17(3):226–236
Vodermaier A, Linden W (2008) Emotional distress screening in Canadian cancer care: a pan-national survey of utilization, tool choices and practice patterns. Oncol Exch 7(4):37–40
Carlson LE, Groff SL, Maciejewski O, Bultz BD (2010) Screening for distress in lung and breast cancer outpatients: a randomized controlled trial. J Clin Oncol 28(33):4884–4891
Jacobsen PB (2009) Clinical practice guidelines for the psychosocial care of cancer survivors. Cancer 115(S18):4419–4429
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370
van’t Spijker A, Trijsburg RW, Duivenvoorden HJ (1997) Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 59:280–293
Singer S, Das-Munshi J, Brähler E (2010) Prevalence of mental health conditions in cancer patients in acute care—a meta-analysis. Ann Oncol 21:925–930
Fletcher RH, Fletcher SW (2005) Clinical epidemiology: the essentials. Lippincott Wilkins & Wilkins, Baltimore
Sollner W, DeVries A, Steixner E et al (2001) How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer 84(2):179–185
Bossuyt PM, Reitsma JB, Bruns DE et al (2003) The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 138(1):W1–W12
Razavi D, Delvaux N, Farvacques C et al (1990) Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiatry 156:79–83
Hopwood P, Howell A, Maguire P (1991) Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer 64:353–356
Razavi D, Delvaux N, Bredart A et al (1992) Screening for psychiatric disorders in a lymphoma out-patient population. Eur J Cancer 28A:1869–1872
Ibbotson T, Maguire P, Selby P et al (1994) Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 30A:37–40
Ramirez AJ, Richards MA, Jarrett SR et al (1995) Can mood disorder in women with breast cancer be identified preoperatively? Br J Cancer 72:1509–1512
Kugaya A, Akechi T, Okuyama T et al (1998) Screening for psychological distress in Japanese cancer patients. Jpn J Clin Oncol 28:333–338
Costantini M, Musso M, Viterbori P et al (1999) Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Supp Care Cancer 7:121–127
Hall A, A’Hern R, Fallowfield L (1999) Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer 35:79–85
Hosaka T, Awazu H, Aoki T et al (1999) Screening for adjustment disorders and major depression in otolaryngology patients using the Hospital Anxiety and Depression Scale. Int J Psychiatry Clin Pract 3:43–48
Le Fevre P, Devereux J, Lawrie SM et al (1999) Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12. Palliat Med 13:399–407
Kugaya A, Akechi T, Okuyama T et al (2000) Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer 88:2817–2823
Cull A, Gould A, House A et al (2001) Validating automated screening for psychological distress by means of computer touch screens for use in routine oncology practice. Br J Cancer 85:1842–1849
Lloyd-Williams M, Friedman T, Rudd N (2001) An analysis of the validity of the Hospital Anxiety and Depression Scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage 22:990–996
Morasso G, Costantini M, Viterbori P et al (2001) Predicting mood disorders in breast cancer patients. Eur J Cancer 37:216–223
Reuter K, Harter M (2001) Screening for mental disorders in cancer patients—discriminant validity of HADS and GHQ-12 assessed by standardized clinical interviews. Int J Methods Psychiatr Res 10:86–96
Love AW, Kissane DW, Bloch S et al (2002) Diagnostic efficiency of the Hospital Anxiety and Depression Scale in women with early stage breast cancer. Aust N Z J Psychiatry 36:246–250
Keller M, Sommerfeldt S, Fischer C et al (2004) Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach. Ann Oncol 15:1243–1249
Katz MR, Kopek N, Waldron J et al (2004) Screening for depression in head and neck cancer. Psychooncology 13:269–280
Love AW, Grabsch B, Clarke DM et al (2004) Screening for depression in women with metastatic breast cancer: a comparison of the Beck Depression Inventory Short Form and the Hospital Anxiety and Depression Scale. Aust N Z J Psychiatry 38:526–531
Akechi T, Okuyama T, Sugawara Y et al (2006) Screening for depression in terminally ill cancer patients in Japan. J Pain Symptom Manage 31:5–12
Smith AB, Wright EP, Rush R et al (2006) Rasch analysis of the dimensional structure of the Hospital Anxiety and Depression Scale. Psychooncology 15:817–827
Néron S, Correa JA, Dajczman E, Kasymjanova G, Kreisman H, Small D (2007) Screening for depressive symptoms in patients with unresectable lung cancer. Support Care Cancer 15:1207–1212
Walker J, Postma K, McHugh GS et al (2007) Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients. J Psychosom Res 63:83–91
Özalp E, Soygür H, Cankurtaran E et al (2008) Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests. Psychooncology 17:668–675
Singer S, Danker H, Dietz A, Hornemann B et al (2008) Screening for mental disorders in laryngeal cancer patients: a comparison of 6 methods. Psychooncology 17:280–286
Castelli L, Binaschi L, Caldera P, Torta R (2009) Depression in lung cancer patients: is the HADS an effective screening tool? Support Care Cancer 17:1129–1132
Grassi L, Sabato S, Rossi E et al (2009) Affective syndromes and their screening in cancer patients with early and stable disease: Italian ICD-10 data and performance of the Distress Thermometer from the Southern European Psycho-Oncology Study (SEPOS). J Affect Disord 114:193–199
Singer S, Kuhnt S, Götze H et al (2009) Hospital anxiety and depression scale cutoff scores for cancer patients in acute care. Br J Cancer 100:908–912
Galbraith RF (1998) A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 7:889–894
Zamora J, Abraira V, Muriel A, et al (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Medical Reserach Methodology 6:31
Bax L, Yu LM, Ikeda N, et al (2006) Development and validation of MIX: Comprehensive free software for meta-analysis of causal research data. BMC Medical Research Methodology 6
Bax L, Yu LM, Ikeda N, et al: MIX: Comprehensive free software for meta-analysis of causal research data, version 1.7. http://mix-for-meta-analysis.info, 2008
First M, Spitzer R, Gibbon M et al (1997) Structured clinical interview for DSM–IV Axis I disorders (SCID-I/P). New York State Psychiatric Institute, Biometrics Research Department, New York
Wing J, Cooper J, Sartorius N (1974) The measurement and classification of psychiatric symptoms. The description and manual for the PSE and CATEGO system. Cambridge University Press, London
Goldberg D, Cooper B, Eastwood M et al (1970) A standardized psychiatric interview for use in community surveys. Brit J Prev Soc Med 24:18–23
Lewis G, Pelosi A, Araya R et al (1992) Measuring psychiatric disorder in the community: a standardized assessment for lay interviewers. Psychol Med 22:465–486
Dean C, Surtees E, Sashidharan S (1983) Comparison of research diagnostic systems in an Edinburgh community sample. Br J Psychiatry 142:247–256
Clarke D, Smith G, Herrman H et al (1998) The Monash Interview for Liaison Psychiatry (MILP): development, reliability and procedural validity. Psychosomatics 39:318–328
Spitzer R, Endicott J (1975) Schedule for Affective Disorders and Schizophrenia (SADS), 2nd edn. New York State Psychiatric Institute, Biometrics Research, New York
Wing J, Babor T, Brugha T et al (1990) SCAN: Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 47:586–593
World Health Organization (1989) The Composite International Diagnostic Interview, Core Version 1.0. WHO, Geneva
Robins L, Helzer J, Croughan J et al (1981) National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics and validity. Arch Gen Psychiatry 38:381–389
Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389
Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Henrichs M, Carnicke CL Jr (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249:751–757
Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52:69–77
Conflict of Interest
Neither of the authors have any conflicts of interest or financial interests associated with this work.
Funding
This study was supported by the Canadian Institute for Health Research CIHR Team for Supportive Cancer Care (#AQC83559) (AV) and a Quinn Research Assistantship (RDM).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vodermaier, A., Millman, R.D. Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer 19, 1899–1908 (2011). https://doi.org/10.1007/s00520-011-1251-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-011-1251-4